Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer

[1] Kitamura Y(1999)Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases J Clin Endocrinol Metab 84 4043-4049

[2] Shimizu K(1993)Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables J Nucl Med 34 1626-1631

[3] Nagahama M(2003)Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 30 974-981

[4] Sugino K(2004)Lung metastases from differentiated thyroid carcinoma. A 40 years’ experience Q J Nucl Med Mol Imaging 48 12-19

[5] Ozaki O(2006)Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2892-2899

[6] Mimura T(2013)SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation Radiographics 33 397-418

[7] Casara D(2001)AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology Endocr Pract 7 202-220

[8] Rubello D(2012)The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0 J Nucl Med 53 1633-1651

[9] Saladini G(2008)Guidelines for radioiodine therapy of differentiated thyroid cancer Eur J Nucl Med Mol Imaging 35 1941-1959

[10] Masarotto G(2009)Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167-1214

[1] Kitamura Y(1999)Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases J Clin Endocrinol Metab 84 4043-4049

[2] Shimizu K(1993)Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables J Nucl Med 34 1626-1631

[3] Nagahama M(2003)Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 30 974-981

[4] Sugino K(2004)Lung metastases from differentiated thyroid carcinoma. A 40 years’ experience Q J Nucl Med Mol Imaging 48 12-19

[5] Ozaki O(2006)Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2892-2899

[6] Mimura T(2013)SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretation Radiographics 33 397-418

[7] Casara D(2001)AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology Endocr Pract 7 202-220

[8] Rubello D(2012)The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0 J Nucl Med 53 1633-1651

[9] Saladini G(2008)Guidelines for radioiodine therapy of differentiated thyroid cancer Eur J Nucl Med Mol Imaging 35 1941-1959

[10] Masarotto G(2009)Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 1167-1214